|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Nov 30, 2022
|
Q3 FY2022
As of Aug 31, 2022
|
Q2 FY2022
As of May 31, 2022
|
Q1 FY2022
As of Feb 28, 2022
|
Q4 FY2021
As of Nov 30, 2021
|
Q3 FY2021
As of Aug 31, 2021
|
Q2 FY2021
As of May 31, 2021
|
Q1 FY2021
As of Feb 28, 2021
|
Q4 FY2020
As of Nov 30, 2020
|
Q3 FY2020
As of Aug 31, 2020
|
Q2 FY2020
As of May 31, 2020
|
Q1 FY2020
As of Feb 29, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaid Expenses and Deposits | ||||||||||||||||||||
| Current Assets of Discontinued Operations | ||||||||||||||||||||
| Accounts receivable, net of provision | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and Equipment, Net (Note 3) - Discontinued Operations | ||||||||||||||||||||
| Cross license | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Loans Payable | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Total loans Payable | ||||||||||||||||||||
| Current Liablilites of Discontinued Operations | ||||||||||||||||||||
| Loans and Notes Payable - Related Parties | ||||||||||||||||||||
| Notes payable, current | ||||||||||||||||||||
| Notes Payable, Related Parties | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable, non-current | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, par value $0.001, 300,000,000 shares authorized; 49,166,697 shares issued and outstanding as of December 31, 2024 and December 31, 2023. | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Series A Preferreds Stock | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B, Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stocks | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Total preferred stock value | ||||||||||||||||||||
| Common stock issuable | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated Other Comprehensive Income | ||||||||||||||||||||
| Deposit on potential merger | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholder's equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
